BACKGROUND: With prior studies having looked at unselected cohorts, we sought to explore the mutational landscape in a high-risk group of head and neck squamous cell carcinoma (HNSCC) tumors. METHODS: A multiplexed polymerase chain reaction (PCR) assay evaluating 68 loci in 15 genes was performed on 64 patients with high-risk HNSCC. Because of the frequent PIK3CA and AKT1 mutations in patients with oropharyngeal carcinoma, we evaluated the relationship between mutation status and both clinical/pathologic variables and tumor control in this subgroup. RESULTS: Seventeen of 64 patients harbored mutations in the assayed loci: 16% in PIK3CA, 9% in TP53, 2% in AKT1, and 2% in epidermal growth factor receptor (EGFR). The frequency of PIK3CA/AKT1 mutations in oropharyngeal and sinonasal primaries was increased compared to other primary sites (35% vs 6%; p = .005). There was no relationship between mutation status and overall survival (OS), disease-specific death, or progression in the oropharyngeal cohort. CONCLUSION: We identified frequent PIK3CA mutations in patients with high-risk HNSCC confined predominantly to the oropharyngeal and sinonasal subsites; for the first time, mutation in AKT1 has been identified in HNSCC.
BACKGROUND: With prior studies having looked at unselected cohorts, we sought to explore the mutational landscape in a high-risk group of head and neck squamous cell carcinoma (HNSCC) tumors. METHODS: A multiplexed polymerase chain reaction (PCR) assay evaluating 68 loci in 15 genes was performed on 64 patients with high-risk HNSCC. Because of the frequent PIK3CA and AKT1 mutations in patients with oropharyngeal carcinoma, we evaluated the relationship between mutation status and both clinical/pathologic variables and tumor control in this subgroup. RESULTS: Seventeen of 64 patients harbored mutations in the assayed loci: 16% in PIK3CA, 9% in TP53, 2% in AKT1, and 2% in epidermal growth factor receptor (EGFR). The frequency of PIK3CA/AKT1 mutations in oropharyngeal and sinonasal primaries was increased compared to other primary sites (35% vs 6%; p = .005). There was no relationship between mutation status and overall survival (OS), disease-specific death, or progression in the oropharyngeal cohort. CONCLUSION: We identified frequent PIK3CA mutations in patients with high-risk HNSCC confined predominantly to the oropharyngeal and sinonasal subsites; for the first time, mutation in AKT1 has been identified in HNSCC.
Authors: Joost L Boormans; Karin G Hermans; Geert J L H van Leenders; Jan Trapman; Paul C M S Verhagen Journal: Int J Cancer Date: 2008-12-01 Impact factor: 7.396
Authors: Ziwei Yu; Paul M Weinberger; Clarence Sasaki; Brian L Egleston; William F Speier; Bruce Haffty; Diane Kowalski; Robert Camp; David Rimm; Eleftherios Vairaktaris; Barbara Burtness; Amanda Psyrri Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-03 Impact factor: 4.254
Authors: Wanglong Qiu; Frank Schönleben; Xiaojun Li; Daniel J Ho; Lanny G Close; Spiros Manolidis; Boyce P Bennett; Gloria H Su Journal: Clin Cancer Res Date: 2006-03-01 Impact factor: 12.531
Authors: Juana Maria Garcia Pedrero; Dario Garcia Carracedo; Cristina Muñoz Pinto; Agustín Herrero Zapatero; Juan Pablo Rodrigo; Carlos Suarez Nieto; Maria Victoria Gonzalez Journal: Int J Cancer Date: 2005-03-20 Impact factor: 7.396
Authors: John D Carpten; Andrew L Faber; Candice Horn; Gregory P Donoho; Stephen L Briggs; Christiane M Robbins; Galen Hostetter; Sophie Boguslawski; Tracy Y Moses; Stephanie Savage; Mark Uhlik; Aimin Lin; Jian Du; Yue-Wei Qian; Douglas J Zeckner; Greg Tucker-Kellogg; Jeffrey Touchman; Ketan Patel; Spyro Mousses; Michael Bittner; Richard Schevitz; Mei-Huei T Lai; Kerry L Blanchard; James E Thomas Journal: Nature Date: 2007-07-04 Impact factor: 69.504
Authors: Nabil F Saba; Malania Wilson; Gregory Doho; Juliana DaSilva; R Benjamin Isett; Scott Newman; Zhuo Georgia Chen; Kelly Magliocca; Michael R Rossi Journal: Head Neck Pathol Date: 2014-09-19
Authors: Daniel L Faden; Fernando Concha-Benavente; Anish B Chakka; Elizabeth L McMichael; Uma Chandran; Robert L Ferris Journal: Head Neck Date: 2019-03-04 Impact factor: 3.147
Authors: Fernando Concha-Benavente; Raghvendra M Srivastava; Sumita Trivedi; Yu Lei; Uma Chandran; Raja R Seethala; Gordon J Freeman; Robert L Ferris Journal: Cancer Res Date: 2015-12-16 Impact factor: 12.701
Authors: Darío García-Carracedo; Maria Ángeles Villaronga; Saúl Álvarez-Teijeiro; Francisco Hermida-Prado; Iñigo Santamaría; Eva Allonca; Laura Suárez-Fernández; Maria Victoria Gonzalez; Milagros Balbín; Aurora Astudillo; Pablo Martínez-Camblor; Gloria H Su; Juan Pablo Rodrigo; Juana María García-Pedrero Journal: Oncotarget Date: 2016-05-17